99 related articles for article (PubMed ID: 3470162)
1. An animal model for evaluation of antigen-specific dialyzable leukocyte extracts therapy of osteosarcoma.
Tsang KY; Pan JF; Fudenberg HH
Clin Immunol Immunopathol; 1987 Mar; 42(3):360-9. PubMed ID: 3470162
[TBL] [Abstract][Full Text] [Related]
2. Transfer of osteosarcoma-specific cell-mediated immunity in hamsters by rabbit dialyzable leukocyte extracts.
Tsang KY; Fudenberg HH; Pan JF
Cell Immunol; 1985 Feb; 90(2):295-302. PubMed ID: 3855389
[TBL] [Abstract][Full Text] [Related]
3. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration.
Wilson GB; Fudenberg HH; Horsmanheimo M
J Lab Clin Med; 1979 May; 93(5):800-18. PubMed ID: 429876
[TBL] [Abstract][Full Text] [Related]
4. Transfer of cell-mediated immunity to Paracoccidioides brasiliensis in hamsters with dialysable leukocyte extracts.
Peraçoli MT; Montenegro MR; Soares AM; Mota NG
J Med Vet Mycol; 1990; 28(1):35-46. PubMed ID: 1694543
[TBL] [Abstract][Full Text] [Related]
5. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
Hashimoto Y; Sekiguchi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
[TBL] [Abstract][Full Text] [Related]
7. Mitigating effects of dialysable leukocyte extract (DLE) on the experimental allergic uveitis (EAU) of the rabbit.
Fricke HJ; Schröder KD; Metzner G; Schröder I; Haroske D; Tilgner S; Sych FJ; Klein S; Jäger L
Allergol Immunopathol (Madr); 1990; 18(5):269-75. PubMed ID: 2097893
[TBL] [Abstract][Full Text] [Related]
8. Liposome-facilitated enhancement of in vitro immunity to human colon cancer.
Sengupta J; Klesius PH; Tom BH
Immunol Invest; 1985 Feb; 14(1):7-26. PubMed ID: 3997212
[TBL] [Abstract][Full Text] [Related]
9. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
Kubasova T; Pázmány T; Horváth M; Pál K; Köteles GJ
Neoplasma; 1991; 38(1):63-8. PubMed ID: 2011211
[TBL] [Abstract][Full Text] [Related]
10. Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins.
Wilson GB; Fudenberg HH; Jonsson HT; Smith CL
Clin Immunol Immunopathol; 1980 May; 16(1):90-102. PubMed ID: 7379353
[No Abstract] [Full Text] [Related]
11. Study of the immunopotentiator effects of dialyzable leukocyte extracts obtained out of leukocytes previously used for interferon production.
Arala-Chaves MP; Porto MT; Kauppinen HL; Massa AA; Myllylä G
Vox Sang; 1982 Nov; 43(5):233-42. PubMed ID: 6183830
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
Wilson GB; Fudenberg HH; Keller RH
J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
[TBL] [Abstract][Full Text] [Related]
13. Serological identification and bioinformatics analysis of immunogenic antigens in osteosarcoma.
Liao B; Ma B; Liu Z; Zhang H; Long H; Yang T; Fan Q
Cancer Biol Ther; 2007 Nov; 6(11):1805-9. PubMed ID: 18032929
[TBL] [Abstract][Full Text] [Related]
14. Isoprinosine as an immunopotentiator in an animal model of human osteosarcoma.
Tsang KY; Fudenberg HH
Int J Immunopharmacol; 1981; 3(4):383-9. PubMed ID: 6174468
[TBL] [Abstract][Full Text] [Related]
15. Dialyzable lymphoid extract (DLE) from mice resistant to STZ-induced diabetogenesis can interrupt the progress of diabetes in STZ-treated CD-1 mice.
Borkowsky W; Pilson R; Lawrence HS
Biotherapy; 1996; 9(1-3):149-57. PubMed ID: 8993774
[TBL] [Abstract][Full Text] [Related]
16. Influence of various forms of dialyzable leukocyte extracts on rat adjuvant arthritis.
Stanciková M; Rovenský J; Pekárek J; Orviský E; Blazícková S; Cech K
Arch Immunol Ther Exp (Warsz); 1994; 42(4):295-9. PubMed ID: 7487370
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of delayed wattle reactivity in chickens with a dialyzable leukocyte extract containing transfer factor.
Giambrone JJ; Klesius PH; Yu M
Poult Sci; 1983 May; 62(5):767-71. PubMed ID: 6878121
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of Salmonella-specific dialyzable leukocyte extracts.
Mikula I; Pistl J; Rosocha J
Vet Immunol Immunopathol; 1992 Apr; 32(1-2):103-21. PubMed ID: 1604793
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with dialyzable leukocyte extracts and studies of their antigen-specific (transfer factor) activity.
Fudenberg HH; Wilson GB; Smith CL
Proc Virchow Pirquet Med Soc; 1980 Dec; 34():3-87. PubMed ID: 6270691
[No Abstract] [Full Text] [Related]
20. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
Wilson GB; Paddock GV; Fudenberg HH
Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
